SURI · ARCA · ETF
Simplify Propel Opportunities ETF (SURI) Price, Holdings & Fees
Simplify Propel Opportunities ETF (SURI) closed at $395.88 on Oct 9, 2026, up 0.48% from the previous close of $393.98.
Share price, past year
1Y +15.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $395.88 |
| Sep 30, 2026 | $383.80 |
| Aug 31, 2026 | $347.50 |
| Jul 31, 2026 | $375.81 |
| Jun 30, 2026 | $377.66 |
| May 29, 2026 | $380.86 |
| Apr 30, 2026 | $387.40 |
| Mar 31, 2026 | $386.90 |
| Feb 27, 2026 | $350.08 |
| Jan 30, 2026 | $350.21 |
| Dec 31, 2025 | $346.37 |
| Nov 28, 2025 | $350.61 |
| Oct 31, 2025 | $371.93 |
Key statistics
- Expense ratio
- 2.56%
- as of May 31, 2026
- Net assets
- $77.3M
- as of Jun 30, 2026
- Holdings
- 39
- as of Jun 30, 2026
- 52-week range
- $341.45 – $397.82
Simplify Propel Opportunities ETF's expense ratio is 2.56%: $256.00 a year on $10,000 invested.
Holdings
Simplify Propel Opportunities ETF held 39 investments worth $77.25M as of Jun 30, 2026. Its largest holding was UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT, at 76.77% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 76.77% | $59.30M |
| 2 | PLAINS GP HOLDINGS LPPAGP | 39.97% | $30.88M |
| 3 | ACHIEVE LIFE SCIENCES INCACHV | 12.11% | $9.35M |
| 4 | MILESTONE PHARMACEUTICALS INCMIST | 5.81% | $4.49M |
| 5 | ACHIEVE LIFE SCIENCES INC | 4.42% | $3.41M |
| 6 | DELCATH SYSTEMS INCDCTH | 4.26% | $3.29M |
| 7 | PHATHOM PHARMACEUTICALS INCPHAT | 3.50% | $2.70M |
| 8 | CORCEPT THERAPEUTICS INCCORT | 2.98% | $2.30M |
| 9 | ABEONA THERAPEUTICS INCABEO | 2.76% | $2.13M |
| 10 | CELLDEX THERAPEUTICS INCCLDX | 2.56% | $1.98M |
| 11 | KYVERNA THERAPEUTICS INCKYTX | 2.11% | $1.63M |
| 12 | COMPASS PATHWAYS PLCCMPS | 2.09% | $1.62M |
| 13 | LEONABIO INCLONA | 1.78% | $1.37M |
| 14 | INVENTIVA SAIVA | 1.53% | $1.18M |
| 15 | AQUESTIVE THERAPEUTICS INCAQST | 1.50% | $1.16M |
| 16 | ARTIVA BIOTHERAPEUTICS INCARTV | 1.27% | $983.14K |
| 17 | ZEVRA THERAPEUTICS INCZVRA | 1.25% | $966.11K |
| 18 | ORCHESTRA BIOMED HOLDINGS INCOBIO | 1.23% | $946.65K |
| 19 | PALISADE BIO INCPALI | 1.22% | $941.63K |
| 20 | TELESAT CANADA / TELESAT LLC | 1.16% | $895.00K |
| 21 | OCULAR THERAPEUTIX INCOCUL | 1.03% | $795.92K |
| 22 | ACHIEVE LIFE SCIEN RTS | 0.97% | $747.73K |
| 23 | EYEPOINT INCEYPT | 0.84% | $649.35K |
| 24 | IMMUNIC INCIMUX | 0.61% | $472.24K |
| 25 | UPSTREAM BIO INCUPB | 0.56% | $429.82K |
Top 25 of 39 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 97.77% |
| Bonds and other debt | 77.92% |
| Repurchase agreements | −75.22% |
| Country | % of fund |
|---|---|
| United States | 89.87% |
| Canada | 6.97% |
| United Kingdom | 2.09% |
| France | 1.53% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, Simplify Propel Opportunities ETF's total return was +19.94%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +6.63% |
| May 31, 2026 | +2.77% |
| Apr 30, 2026 | +9.45% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Simplify Propel Opportunities ETF
- Ticker
- SURI
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- Simplify Exchange Traded Funds
- SEC series ID
- S000078061
- SEC CIK
- 0001810747
- Fractional shares
- No
Recent SEC filings
- Aug 24, 2026
- 485BPOSProspectus updateSep 28, 2026
- Sep 8, 2026
- 485BPOSProspectus updateAug 28, 2026
- 485BPOSProspectus updateJun 26, 2026
- 485BPOSProspectus updateMay 18, 2026
- 485BPOSProspectus updateApr 6, 2026
- Mar 4, 2026
Shareholder reports and prospectuses are filed by Simplify Exchange Traded Funds, the trust behind Simplify Propel Opportunities ETF, and cover all of its funds.
Frequently asked questions
What is SURI's price?
Simplify Propel Opportunities ETF (SURI) closed at $395.88 on Oct 9, 2026, up 0.48% from the previous close of $393.98.
What is SURI's expense ratio?
Simplify Propel Opportunities ETF's expense ratio is 2.56%: $256.00 a year on $10,000 invested.
What does SURI hold?
Simplify Propel Opportunities ETF held 39 investments worth $77.25M as of Jun 30, 2026. Its largest holding was UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT, at 76.77% of the fund. Its five largest holdings were UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT, PLAINS GP HOLDINGS LP, ACHIEVE LIFE SCIENCES INC, MILESTONE PHARMACEUTICALS INC, ACHIEVE LIFE SCIENCES INC.
How has SURI performed?
Over the 3 months to Jun 30, 2026, Simplify Propel Opportunities ETF's total return was +19.94%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 24, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of May 31, 2026. Prices are generated sample data for development. Data sources and disclosures